MedTrace Logo

Evaluation of Response to a Course of Repetitive Transcranial Magnetic Stimulation Using Vocal Biomarkers

NCT06451835 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2025-03-12

No results posted yet for this study

Summary

Voice recordings taken prior to the start of repetitive transcranial magnetic stimulation (rTMS) therapy will be used to develop a predictive model of treatment response using machine learning for patients with major depressive disorders (MDD).

Conditions

Interventions

DEVICE

repetitive transcranial magnetic stimulation (rTMS)

rTMS will be applied 5 days out of 7 for 6 weeks, for a total of 30 sessions. The area stimulated will be the left dorsolateral prefrontal cortex, at a frequency of 10 Hz, at 110% of motor threshold for approximately 20 minutes (i.e. 3,000 stimulations per session).

Sponsors & Collaborators

  • Callyope

    collaborator INDUSTRY

  • GCS CIPS

    lead OTHER

Principal Investigators

  • Fariba KABIRIAN, MD · France Chief Medical Officer, Clariane

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-13
Primary Completion
2025-04-15
Completion
2025-06-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451835 on ClinicalTrials.gov